5VWL
 
 | |
2NV3
 | | Solution structure of L8A mutant of HIV-1 myristoylated matrix protein | | Descriptor: | Gag polyprotein, MYRISTIC ACID | | Authors: | Saad, J.S, Loeliger, E, Luncsford, P, Liriano, M, Tai, J, Kim, A, Miller, J, Joshi, A, Freed, E.O, Summers, M.F. | | Deposit date: | 2006-11-10 | | Release date: | 2007-02-06 | | Last modified: | 2024-10-30 | | Method: | SOLUTION NMR | | Cite: | Point mutations in the HIV-1 matrix protein turn off the myristyl switch.
J.Mol.Biol., 366, 2007
|
|
2H3V
 | | Structure of the HIV-1 Matrix protein bound to di-C8-phosphatidylinositol-(4,5)-bisphosphate | | Descriptor: | Gag polyprotein, [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | | Authors: | Saad, J.S, Miller, J, Tai, J, Kim, A, Ghanam, R.H, Summers, M.F. | | Deposit date: | 2006-05-23 | | Release date: | 2006-07-25 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc.Natl.Acad.Sci.Usa, 103, 2006
|
|
2K4H
 | | Solution structure of the HIV-2 myristoylated Matrix protein | | Descriptor: | HIV-2 myristoylated matrix protein, MYRISTIC ACID | | Authors: | Saad, J.S, Ablan, S.D, Ghanam, R.H, Kim, A, Andrews, K, Nagashima, K, Freed, E.O, Summers, M.F. | | Deposit date: | 2008-06-08 | | Release date: | 2008-08-12 | | Last modified: | 2024-10-30 | | Method: | SOLUTION NMR | | Cite: | Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.
J.Mol.Biol., 382, 2008
|
|
2H3I
 | | Solution structure of the HIV-1 myristoylated Matrix protein | | Descriptor: | Gag polyprotein, MYRISTIC ACID | | Authors: | Saad, J.S, Miller, J, Tai, J, Kim, A, Ghanam, R.H, Summers, M.F. | | Deposit date: | 2006-05-22 | | Release date: | 2006-07-25 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc.Natl.Acad.Sci.Usa, 103, 2006
|
|
2K4I
 | | Solution structure of HIV-2 myrMA bound to di-C4-PI(4,5)P2 | | Descriptor: | (2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6-TRIHYDROXY-4,5-BIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1,2-DIYL DIBUTANOATE, HIV-2 myristoylated matrix protein, MYRISTIC ACID | | Authors: | Saad, J.S, Ablan, S.D, Ghanam, R.H, Kim, A, Andrews, K, Nagashima, K, Freed, E.O, Summers, M.F. | | Deposit date: | 2008-06-08 | | Release date: | 2008-08-12 | | Last modified: | 2014-01-29 | | Method: | SOLUTION NMR | | Cite: | Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.
J.Mol.Biol., 382, 2008
|
|
2K4E
 | | Solution structure of the HIV-2 UNMYRISTOYLATED MATRIX PROTEIN | | Descriptor: | HIV-2 unmyristoylated matrix protein | | Authors: | Saad, J.S, Ablan, S.D, Ghanam, R.H, Kim, A, Andrews, K, Nagashima, K, Freed, E.O, Summers, M.F. | | Deposit date: | 2008-06-07 | | Release date: | 2008-08-12 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.
J.Mol.Biol., 382, 2008
|
|
2H3Z
 | | Structure of the HIV-1 matrix protein bound to di-C4-phosphatidylinositol-(4,5)-bisphosphate | | Descriptor: | (2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6-TRIHYDROXY-4,5-BIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1 ,2-DIYL DIBUTANOATE, Gag polyprotein | | Authors: | Saad, J.S, Miller, J, Tai, J, Kim, A, Ghanam, R.H, Summers, M.F. | | Deposit date: | 2006-05-23 | | Release date: | 2006-07-25 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc.Natl.Acad.Sci.Usa, 103, 2006
|
|
2H3Q
 | | Solution structure of HIV-1 myrMA bound to di-C4-phosphatidylinositol-(4,5)-bisphosphate | | Descriptor: | (2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6-TRIHYDROXY-4,5-BIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1 ,2-DIYL DIBUTANOATE, Gag polyprotein, MYRISTIC ACID | | Authors: | Saad, J.S, Miller, J, Tai, J, Kim, A, Ghanam, R.H, Summers, M.F. | | Deposit date: | 2006-05-22 | | Release date: | 2006-07-25 | | Last modified: | 2024-10-30 | | Method: | SOLUTION NMR | | Cite: | Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc.Natl.Acad.Sci.Usa, 103, 2006
|
|
2H3F
 | | Solution structure of the HIV-1 MA protein | | Descriptor: | Gag polyprotein | | Authors: | Saad, J.S, Miller, J, Tai, J, Kim, A, Ghanam, R.H, Summers, M.F. | | Deposit date: | 2006-05-22 | | Release date: | 2006-07-25 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Proc.Natl.Acad.Sci.Usa, 103, 2006
|
|
2JMG
 | | Solution structure of V7R mutant of HIV-1 myristoylated matrix protein | | Descriptor: | Gag polyprotein, MYRISTIC ACID | | Authors: | Saad, J.S, Loeliger, E, Luncsford, P, Liriano, M, Tai, J, Kim, A, Miller, J, Joshi, A, Freed, E.O, Summers, M.F. | | Deposit date: | 2006-11-11 | | Release date: | 2007-02-06 | | Last modified: | 2023-12-20 | | Method: | SOLUTION NMR | | Cite: | Point mutations in the HIV-1 matrix protein turn off the myristyl switch.
J.Mol.Biol., 366, 2007
|
|
7TBP
 | | X-ray structure of the HIV-1 myristoylated matrix protein | | Descriptor: | CITRIC ACID, Capsid protein p24, MYRISTIC ACID, ... | | Authors: | Green, T.J, Saad, J.S, Samal, A.B. | | Deposit date: | 2021-12-22 | | Release date: | 2022-06-22 | | Last modified: | 2023-10-18 | | Method: | X-RAY DIFFRACTION (2.151 Å) | | Cite: | Atomic view of the HIV-1 matrix lattice; implications on virus assembly and envelope incorporation.
Proc.Natl.Acad.Sci.USA, 119, 2022
|
|
7M1W
 | |
7JXR
 | | Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 1 | | Descriptor: | HEXAETHYLENE GLYCOL, Matrix protein, SULFATE ION | | Authors: | Green, T.J, Eastep, G.N, Ghanam, R.H, Saad, J.S. | | Deposit date: | 2020-08-27 | | Release date: | 2021-04-14 | | Last modified: | 2023-10-18 | | Method: | X-RAY DIFFRACTION (2.04 Å) | | Cite: | Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
J.Biol.Chem., 296, 2021
|
|
7JXS
 | | Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 2 | | Descriptor: | ACETATE ION, DODECAETHYLENE GLYCOL, HEXAETHYLENE GLYCOL, ... | | Authors: | Green, T.J, Eastep, G.N, Ghanam, R.H, Saad, J.S. | | Deposit date: | 2020-08-27 | | Release date: | 2021-04-14 | | Last modified: | 2023-10-18 | | Method: | X-RAY DIFFRACTION (2.35 Å) | | Cite: | Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
J.Biol.Chem., 296, 2021
|
|
1KSB
 | | Relationship of Solution and Protein-Bound Structures of DNA Duplexes with the Major Intrastrand Cross-Link Lesions Formed on Cisplatin Binding to DNA | | Descriptor: | 5'-D(*AP*GP*GP*CP*CP*GP*GP*AP*G)-3', 5'-D(*CP*TP*CP*CP*GP*GP*CP*CP*T)-3', Cisplatin | | Authors: | Marzilli, L.G, Saad, J.S, Kuklenyik, Z, Keating, K.A, Xu, Y. | | Deposit date: | 2002-01-11 | | Release date: | 2002-01-17 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Relationship of solution and protein-bound structures of DNA duplexes with the major intrastrand cross-link lesions formed on cisplatin binding to DNA.
J.Am.Chem.Soc., 123, 2001
|
|
6CV8
 | | HADDOCK structure of the Rous sarcoma virus matrix protein (M-domain) in complex with inositol 1,4,5-trisphosphate | | Descriptor: | D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE, Matrix protein p19 | | Authors: | Vlach, J, Saad, J.S. | | Deposit date: | 2018-03-27 | | Release date: | 2018-10-24 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Structural basis for targeting avian sarcoma virus Gag polyprotein to the plasma membrane for virus assembly.
J. Biol. Chem., 293, 2018
|
|
6CE5
 | |
6CUS
 | |
6CW4
 | | HADDOCK structure of the Rous sarcoma virus matrix protein (M-domain) in complex with inositol 1,3,5-trisphosphate | | Descriptor: | (1R,2S,3r,4R,5S,6s)-2,4,6-trihydroxycyclohexane-1,3,5-triyl tris[dihydrogen (phosphate)], Matrix protein p19 | | Authors: | Vlach, J, Saad, J.S. | | Deposit date: | 2018-03-29 | | Release date: | 2018-10-24 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Structural basis for targeting avian sarcoma virus Gag polyprotein to the plasma membrane for virus assembly.
J. Biol. Chem., 293, 2018
|
|
2L8T
 | | Staphylococcus aureus pathogenicity island 1 protein gp6, an internal scaffold in size determination | | Descriptor: | Transposon Tn557 toxic shock syndrome toxin-1 | | Authors: | Dearborn, A.D, Spilman, M.S, Damle, P.K, Chang, J.R, Monroe, E.B, Saad, J.S, Christie, G.E, Dokland, T. | | Deposit date: | 2011-01-24 | | Release date: | 2011-08-17 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | The Staphylococcus aureus Pathogenicity Island 1 Protein gp6 Functions as an Internal Scaffold during Capsid Size Determination.
J.Mol.Biol., 412, 2011
|
|
